While still in the developmental stage, genetic and cell-based therapies hold some promise for people with Parkinson’s disease (PD). This webinar will review what those considering gene-based or cell-based therapy may expect in terms of symptom management and disease progression.
Roger Barker, BA, MBBS, MRCP, PhD
University of Cambridge
Dr. Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at the Addenbrooke’s Hospital Cambridge. He is a PI in the MRC-Wellcome Stem Cell Institute in Cambridge and Director of the MRC funded UKRMP Stem and Engineered cell hub.
He trained at Oxford University and St Thomas Hospital Medical School before qualifying in 1986. He completed his medical training before undertaking a PhD in Cambridge on neural grafting for Parkinson’s Disease. He then completed his neurology training in Cambridge, London and Norwich before setting up his own research group in 1997.
His research seeks to better define the clinical heterogeneity of two common neurodegenerative disorders of the CNS- namely Parkinson’s (PD) and Huntington’s disease (HD). This has helped him define the best way by which to take new therapies into the clinic including novel experimental therapeutics such as cell and gene therapies as well as drug repurposing trials.
Special thanks to our sponsor:
PD Health @ Home is presented by the Light of Day Foundation, whose generosity has made this programming possible.
Join us every Monday as our expert speaker leads you in guided relaxation techniques to help boost brain power and reduce stress.
This webinar offers insights into the Institute for Music and Neurologic Function (IMNF's) Music has Power® for Parkinson’s Disease (PD) program.
A balanced diet is important for people with Parkinson’s disease.